Company profile: Cordant Health Solutions
1.1 - Company Overview
Company description
- Provider of drug testing and case-management solutions for health, chronic pain, and criminal justice, including Cordant Sentry for automated patient testing randomization, real-time results, and compliance alerts; urine, oral fluid, hair, and blood drug testing; and behavioral health solutions with laboratory testing, pharmacy services, and adherence monitoring.
Products and services
- Cordant Sentry™: Online-integrated case-management platform orchestrating automated patient testing randomization, delivering real-time drug test results, and triggering compliance alerts to monitor adherence for criminal justice, pain management, and healthcare programs
- Urine Drug Testing: Urine-based testing detects prescribed and non-prescribed medications and illicit substances in samples, offering insights into patient compliance and drug use patterns for monitoring programs
- Behavioral Health Solutions: Evidence-based programs delivering laboratory testing, pharmacy services, and adherence monitoring tools to support substance use and mental health treatment and recovery, coordinating payers, clinicians, and organizations.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Cordant Health Solutions
Adaltis
HQ: Italy
Website
- Description: Provider of in-vitro diagnostic systems and reagents to detect viral infections, diagnose immune system diseases, and measure hormone responses. Offers integrated platforms and automation including All-in One MDx for nucleic acid extraction and real-time PCR, Personal LAB and NEXgen microplate analyzers for ELISA/IFA, MOLgen syndromic PCR panels, AMPLIlab real-time PCR, and EXTRAlab liquid handling workstation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Adaltis company profile →
Sebia
HQ: United States
Website
- Description: Provider of clinical protein electrophoresis equipment and reagents for in-vitro diagnostic (IVD) testing. Systems analyze proteins to screen and monitor diseases and conditions, primarily oncology (Multiple Myeloma), metabolic disorders such as Diabetes, and Hemoglobinopathy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sebia company profile →
IDL Biotech
HQ: Sweden
Website
- Description: Provider of in vitro diagnostic (IVD) tests for the healthcare sector, developing, producing, and marketing worldwide. Active in oncology and bacteriology through manufacturing various tumor markers and a rapid Salmonella typhoid test.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full IDL Biotech company profile →
NanoRepro
HQ: Germany
Website
- Description: Provider of rapid medical self-tests and diagnostics, developing, manufacturing, and distributing products for domestic and clinical use across women's health, fertility, prevention, family planning, health care, allergies, and food intolerance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NanoRepro company profile →
Cylex
HQ: United States
Website
- Description: Provider of in vitro diagnostic products designed to illuminate immunity in transplant medicine.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cylex company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Cordant Health Solutions
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Cordant Health Solutions
2.2 - Growth funds investing in similar companies to Cordant Health Solutions
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Cordant Health Solutions
4.2 - Public trading comparable groups for Cordant Health Solutions
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →